|
NL153305B
(nl)
*
|
1969-06-05 |
1977-05-16 |
Philips Nv |
Verwarmingsinstallatie, in het bijzonder geschikt voor voertuigen, voorzien van een heetgasmotor.
|
|
US3717993A
(en)
*
|
1970-11-02 |
1973-02-27 |
Gen Motors Corp |
Preheater assembly for stirling engine
|
|
NL7205878A
(OSRAM)
*
|
1972-04-29 |
1973-10-31 |
|
|
|
JPS62116867A
(ja)
*
|
1985-11-16 |
1987-05-28 |
アイシン精機株式会社 |
冷凍装置
|
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
|
US6514530B2
(en)
|
1997-09-09 |
2003-02-04 |
Alza Corporation |
Dosage form comprising means for changing drug delivery shape
|
|
US20040062799A1
(en)
*
|
1997-09-29 |
2004-04-01 |
Ayer Atul D. |
Therapeutic composition and delivery system for administering drug
|
|
ES2172944T3
(es)
|
1997-12-05 |
2002-10-01 |
Alza Corp |
Forma de dosificacion osmotica que comprende un primer y un segundo revestimiento.
|
|
AU773642C
(en)
|
1997-12-22 |
2006-04-06 |
Mundipharma Pty Limited |
Opioid agonist/antagonist combinations
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
|
US20010038855A1
(en)
*
|
1998-06-05 |
2001-11-08 |
Desjardin Michael A. |
Dosage form for administering prescribed dose
|
|
US6733783B2
(en)
|
2000-10-30 |
2004-05-11 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
|
CN1525851A
(zh)
|
2001-05-11 |
2004-09-01 |
������ҩ������˾ |
抗滥用阿片样物质控释剂型
|
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
EP2316428A1
(en)
|
2002-04-05 |
2011-05-04 |
Euro-Celtique S.A. |
Matrix for sustained, invariant and independent release of active compounds
|
|
US20070259014A1
(en)
*
|
2003-06-20 |
2007-11-08 |
Vgx Pharmaceuticals, Inc. |
Compositions for and Methods for Treating Hiv
|
|
PL1663229T3
(pl)
|
2003-09-25 |
2010-09-30 |
Euro Celtique Sa |
Farmaceutyczne kombinacje hydrokodonu i naltreksonu
|
|
TWI483944B
(zh)
|
2004-03-30 |
2015-05-11 |
Euro Celtique Sa |
含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
|
EP1604667A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
|
HUE037643T2
(hu)
|
2004-06-12 |
2018-09-28 |
Collegium Pharmaceutical Inc |
Visszaélésre nem alkalmas gyógyszerkészítmények
|
|
AP2274A
(en)
*
|
2005-01-28 |
2011-08-19 |
Euro Celtiques Sa |
Alcohol resistant dosage forms.
|
|
EP1695700A1
(en)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
|
EP1813276A1
(en)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
|
WO2010099508A1
(en)
|
2009-02-26 |
2010-09-02 |
Theraquest Biosciences, Inc. |
Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
|
|
KR20140141727A
(ko)
|
2009-03-10 |
2014-12-10 |
유로-셀티큐 에스.에이. |
옥시코돈 및 날록손을 포함하는 즉시 방출 제약 조성물
|
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
US8808740B2
(en)
|
2010-12-22 |
2014-08-19 |
Purdue Pharma L.P. |
Encased tamper resistant controlled release dosage forms
|
|
PH12013501345A1
(en)
|
2010-12-23 |
2022-10-24 |
Purdue Pharma Lp |
Tamper resistant solid oral dosage forms
|
|
ES2647949T3
(es)
|
2012-07-16 |
2017-12-27 |
Rhodes Technologies |
Proceso para la síntesis mejorada de opioides
|
|
SG11201407986QA
(en)
|
2012-07-16 |
2015-02-27 |
Rhodes Technologies |
Process for improved opioid synthesis
|
|
PE20151301A1
(es)
|
2013-02-05 |
2015-09-16 |
Purdue Pharma Lp |
Formulaciones farmaceuticas resistentes a la manipulacion indebida
|
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
WO2015011189A1
(en)
|
2013-07-23 |
2015-01-29 |
Euro-Celtique S.A. |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
|
CN106029669B
(zh)
|
2014-01-15 |
2018-04-13 |
罗德科技公司 |
改进的羟二氢吗啡酮合成的方法
|
|
WO2015107471A1
(en)
|
2014-01-15 |
2015-07-23 |
Rhodes Technologies |
Process for improved oxycodone synthesis
|
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
|
US10736905B1
(en)
|
2016-09-09 |
2020-08-11 |
Shahin Fatholahi |
Nefopam dosage forms and methods of treatment
|
|
US11446311B2
(en)
|
2017-09-08 |
2022-09-20 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
|
US10736874B1
(en)
|
2017-09-08 |
2020-08-11 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
|
CN114174660B
(zh)
*
|
2019-05-21 |
2024-10-11 |
通用电气公司 |
能量转换设备和系统
|